{"id":"low-dose-corticosteroids-dexamethasone","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Mood changes"},{"rate":null,"effect":"Infection risk (immunosuppression)"},{"rate":null,"effect":"Hypertension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone acts as a glucocorticoid receptor agonist, translocating to the nucleus to modulate gene expression and suppress inflammatory pathways. At low doses, it reduces excessive immune activation and inflammatory responses without causing severe immunosuppression. This mechanism makes it useful in conditions characterized by harmful inflammation, such as severe COVID-19 and other inflammatory diseases.","oneSentence":"Dexamethasone is a synthetic corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:19:34.168Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 (hospitalized patients requiring oxygen support)"},{"name":"Severe inflammatory conditions"}]},"trialDetails":[{"nctId":"NCT06780202","phase":"PHASE2","title":"Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-27","conditions":"Foot Injuries and Disorders, Ankle Injuries and Disorders, Achilles Tendon Injury","enrollment":180},{"nctId":"NCT05440851","phase":"NA","title":"Platform of Randomized Adaptive Clinical Trials in Critical Illness","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-04-30","conditions":"Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication, Mechanical Ventilation Pressure High","enrollment":6250},{"nctId":"NCT03020030","phase":"PHASE3","title":"Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-03-03","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":560},{"nctId":"NCT06023641","phase":"PHASE2","title":"Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-03-13","conditions":"Rhabdomyosarcoma","enrollment":135},{"nctId":"NCT05707156","phase":"","title":"Prospective Observational Study on the Incidence of Opportunistic Fungal Infections","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2023-07-05","conditions":"Pneumocystis Jirovecii Infection, Pneumocystis, Cryptococcosis","enrollment":12032},{"nctId":"NCT02649790","phase":"PHASE1, PHASE2","title":"Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications","status":"COMPLETED","sponsor":"Karyopharm Therapeutics Inc","startDate":"2016-01","conditions":"Relapsed/Refractory Multiple Myeloma (RRMM), Metastatic Colorectal Cancer (mCRC), Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":277},{"nctId":"NCT05401812","phase":"PHASE2","title":"Glucocorticoid Therapy for Acute Respiratory Distress Syndrome","status":"WITHDRAWN","sponsor":"National Taiwan University Hospital","startDate":"2022-07-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT02770807","phase":"PHASE3","title":"Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients","status":"COMPLETED","sponsor":"Quince Therapeutics S.p.A.","startDate":"2017-03-02","conditions":"Nervous System Disease, Genetic Syndrome","enrollment":176},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT04724629","phase":"PHASE3","title":"Survival TRial Using CytoKines in COVID-19 (STRUCK Trial)","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2021-01-05","conditions":"Covid19","enrollment":60},{"nctId":"NCT04733144","phase":"PHASE1","title":"Bioequivalence Study of Prednisolone and Dexamethasone","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2021-03-04","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT04726098","phase":"PHASE4","title":"Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19","status":"COMPLETED","sponsor":"Manuel Taboada Muñiz","startDate":"2021-01-15","conditions":"Covid19, Corticosteroids","enrollment":198},{"nctId":"NCT04380818","phase":"NA","title":"Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19","status":"UNKNOWN","sponsor":"Grupo de Investigación Clínica en Oncología Radioterapia","startDate":"2020-06-05","conditions":"Pneumonia, Viral","enrollment":106},{"nctId":"NCT04395105","phase":"PHASE3","title":"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial","status":"TERMINATED","sponsor":"Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno","startDate":"2020-05-21","conditions":"Respiratory Distress Syndrome, Adult, Covid-19","enrollment":100},{"nctId":"NCT01857232","phase":"PHASE2","title":"Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy","status":"COMPLETED","sponsor":"Acacia Pharma Ltd","startDate":"2013-10","conditions":"CINV","enrollment":342},{"nctId":"NCT00331162","phase":"PHASE4","title":"Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2005-02","conditions":"Graft Rejection","enrollment":222},{"nctId":"NCT01422733","phase":"EARLY_PHASE1","title":"Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2018-06-01","conditions":"Hyperandrogenemia, Obesity, Polycystic Ovary Syndrome","enrollment":""},{"nctId":"NCT02084134","phase":"NA","title":"Peri-Operative Steroid Management in Patients","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2012-03","conditions":"Pituitary Adenoma, Pituitary Diseases","enrollment":43},{"nctId":"NCT02426736","phase":"PHASE4","title":"Effect of Dexamethasone Dose and Route on Duration of Interscalene Block After Outpatient Shoulder Surgery","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2015-06-25","conditions":"Pain, Postoperative, Disorder of Shoulder","enrollment":280},{"nctId":"NCT00005777","phase":"PHASE3","title":"Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)","status":"TERMINATED","sponsor":"NICHD Neonatal Research Network","startDate":"1998-02","conditions":"Bronchopulmonary Dysplasia, Respiratory Distress Syndrome, Infant, Newborn","enrollment":220},{"nctId":"NCT00548483","phase":"PHASE2","title":"Comparison of High Dose and Low Dose Dexamethasone in Preventing Post-Extubation Airway Obstruction in Adults","status":"UNKNOWN","sponsor":"Mackay Memorial Hospital","startDate":"2007-04","conditions":"Airway Obstruction","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Low-dose corticosteroids: Dexamethasone","genericName":"Low-dose corticosteroids: Dexamethasone","companyName":"University of Oxford","companyId":"university-of-oxford","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone is a synthetic corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. Used for COVID-19 (hospitalized patients requiring oxygen support), Severe inflammatory conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}